1. Introduction {#sec1-marinedrugs-16-00040}
===============

Soft corals of genus *Sinularia* (*Alcyoniidae*) have been reported to be a rich source of novel structures and bioactive terpenoids and steroids \[[@B1-marinedrugs-16-00040]\]. Previous studies on the sample of *Sinularia nanolobata* Verseveldt have resulted in the isolation of diterpenoids \[[@B2-marinedrugs-16-00040],[@B3-marinedrugs-16-00040],[@B4-marinedrugs-16-00040],[@B5-marinedrugs-16-00040]\] and sesquiterpenoids \[[@B3-marinedrugs-16-00040],[@B4-marinedrugs-16-00040]\], and steroids \[[@B5-marinedrugs-16-00040],[@B6-marinedrugs-16-00040]\]. During the course of our search of bioactive compounds from marine organisms, a chemical investigation on the secondary metabolites of *S. nanolobata* from Taiwanese waters has afforded a novel tetranorditerpenoid, sinubatin A (**1**) (possessing an unprecedented carbon skeleton), a new norditerpenoid, sinubatin B (**2**) (a 4,5-epoxycaryophyllene possessing an unusual methylfuran moiety side chain), and gibberosin J (**3**) ([Figure 1](#marinedrugs-16-00040-f001){ref-type="fig"}). The structures of **1** and **2** were determined by extensive spectroscopic analysis. The chemical structure of gibberosin J (**3**) was determined by comparison of its infrared (IR), high resolution electron spray ionization mass spectrum (HR-ESI-MS), and nuclear magnetic resonance (NMR) spectroscopic data with the literature data \[[@B7-marinedrugs-16-00040]\].

2. Results and Discussion {#sec2-marinedrugs-16-00040}
=========================

Chromatographic separation on the acetone extract resulted in the isolation of two new terpenoids, sinubatin A and B (**1** and **2**), as well as a known compound, gibberosin J (**3**). The HR-ESI-MS, ^13^C NMR, and DEPT spectroscopic data of sinubatin A (**1**) established its molecular formula as C~19~H~28~O~5~. ^13^C NMR and DEPT spectrum of **1** showed the presence of four methyl, five sp^3^ methylene, four sp^3^ methine, one sp^2^ methylene, two sp^3^ quaternary, one sp^2^ quaternary, and two carbonyl carbons. The presence of an exomethylene in **1** was shown by the NMR data \[δ~H~ 4.90 (1H, s), 5.01 (1H, s); δ~C~ 114.0 (CH~2~), 150.7 (C)\] ([Table 1](#marinedrugs-16-00040-t001){ref-type="table"}). The NMR data \[δ~C~ 59.6 (C), 63.8 (CH), δ~H~ 2.92 (1H, dd, *J* = 10.8, 4.0 Hz)\] ([Table 1](#marinedrugs-16-00040-t001){ref-type="table"}) indicated a trisubstituted epoxide in **1**. The NMR spectrum contained signals for a secondary acetoxyl \[δ~H~ 4.74 (1H, s), 2.15 (3H, s); δ~C~ 79.4 (CH), 20.6 (CH~3~), and 170.8 (C)\] ([Table 1](#marinedrugs-16-00040-t001){ref-type="table"}). The presence of a methyl ester \[δ~H~ 3.71 (3H, s); δ~C~ 51.9 (CH~3~), 169.2 (C)\] was shown in the NMR spectrum. From the data of ^1^H--^1^H COSY correlations ([Figure 2](#marinedrugs-16-00040-f002){ref-type="fig"}), we established two partial structures of consecutive proton systems extending from H-10 to H-3 through H-9 and from H-16 to H-7 through H-4. HMBC correlations of (a) CH~3~-16 to C-3, C-4, and C-5, (b) H~2~-15 to C-7, C-8, and C-9, (c) CH~3~-14 to C-1, C-10, C-11, and C-12, (d) CH-12 to C-10, C-11,C-13, and C-14 connected four partial structures and concluded the planar structure of **1**, as shown in [Figure 2](#marinedrugs-16-00040-f002){ref-type="fig"}. The above functionalities revealed that sinubatin A (**1**) possesses a novel xeniaphyllane-derived tetranorditerpene skeleton. The relative configuration of **1** was established from a NOESY experiment. NOE correlations of H~3~-14/H-9 and H~3~-16/H-9 pointed H~3~-14, H-9 and H~3~-16 to be on the β-side of the molecule. NOE correlation of H-1/H-5 suggested H-1 and H-5 were on the α-side of the molecule. ([Figure 3](#marinedrugs-16-00040-f003){ref-type="fig"}).

HR-ESI-MS of sinubatin B (**2**) showed a pseudomolecular ion peak at *m*/*z* 309.1842 \[M + Na\]^+^, consistent with the molecular formula C~19~H~26~O~2~, and seven degrees of unsaturation. The ^13^C NMR spectrum ([Table 2](#marinedrugs-16-00040-t002){ref-type="table"}) of **2** displayed 19 carbon signals, and a DEPT experiments indicated the presence of three methyl, five sp^3^ methylene, three sp^3^ methine, two sp^2^ methine, one sp^2^ methylene, two sp^3^ quaternary, and three sp^2^ quaternary carbons. The ^13^C and ^1^H NMR spectra ([Table 2](#marinedrugs-16-00040-t002){ref-type="table"}) revealed the presence of a trisubstituted epoxides \[δ~H~ 2.92 (dd, *J* = 10.4, 4.0 Hz); δ~C~ 63.7 (CH) and 59.7 (C)\], a 2,5-disubstituted furan \[δ~H~ 5.83 (d, *J* = 4.0 Hz), 5.84 (dd, *J* = 4.0, 0.8 Hz), and 2.28 (d, *J* = 0.8 Hz); δ~C~ 103.7 (CH), 105.8 (CH), 150.6 (C), 160.2 (C), 13.6 (CH~3~)\] \[[@B8-marinedrugs-16-00040]\] and an exomethylene \[δ~H~ 5.09 (s) and 4.93 (s); δ~C~ 113.5 (CH~2~) and 151.4 (C)\]. Thus, the tetracyclic structure of **2** was revealed. From the ^1^H--^1^H COSY spectrum of **2**, it was also possible to identify two different structural units ([Figure 2](#marinedrugs-16-00040-f002){ref-type="fig"}), which were assembled with the assistance of an HMBC experiments. Key HMBC correlations ([Figure 2](#marinedrugs-16-00040-f002){ref-type="fig"}) of H~3~-19 to C-3, C-4, and C-5; H~3~-18 to C-7, C-8, and C-9; H~3~-17 to C-1, C-10, C-11, and C-12 indicated that compound **2** was a 4,5-epoxycaryophyllene having a methylfuran on C-11. The relative configuration of **2** was determined from a NOESY experiment. NOE correlations of H~3~-19/H-9 and H~3~-17/H-9 suggested H~3~-19, H-9 and H~3~-17 to be on the β-side of the molecule. NOE correlation of H-1/H-5 indicated H-1 and H-5 were on the α-side of the molecule. ([Figure 3](#marinedrugs-16-00040-f003){ref-type="fig"}). Compound **2** was the first caryophyllene possessing a methylfuran on C-11.

Compounds **1**--**3** were tested for cytotoxicity against mouse lymphocytic leukemia (P-388), human colon adenocarcinoma (HT-29), and human lung epithelial carcinoma (A-549) tumor cell lines. Compound **3** exhibited cytotoxicity against P-388, A549, and HT-29 with ED~50~ values of of 1.0, 1.2, and 0.5 μg/mL, respectively. However, compounds **1** and **2** were not cytotoxic to P-388, A549 and HT-29 cell lines. Compounds **1**--**3** were also examined for antiviral activity against human cytomegalovirus (HCMV) and did not show anti-HCMV activity.

3. Experimental Section {#sec3-marinedrugs-16-00040}
=======================

3.1. General Experimental Procedures {#sec3dot1-marinedrugs-16-00040}
------------------------------------

Optical rotations were obtained on a JASCO P1020 digital polarimeter (Tokyo, Japan). UV and IR spectra were determined on JASCO V-650 (JASCO, Tokyo, Japan) and JASCO FT/IR-4100 spectrophotometers (JASCO, Tokyo, Japan), respectively. NMR spectra were recorded on a Varian MR 400 NMR spectrometer (Santa Clara, CA, USA) at 400 MHz for ^1^H and 100 MHz for ^13^C. ^1^H NMR chemical shifts are expressed in δ (ppm) referring to the solvent peak δ~H~ 7.27 for CHCl~3~ and coupling constants are expressed in Hertz (Hz). ^13^C NMR chemical shifts are expressed in δ (ppm) referring to the solvent peak δ~C~ 77.0 for CDCl~3~. MS were obtained by a Bruker APEX II mass spectrometer (Bruker, Bremen, Germany). Precoated silica gel plates (Merck, Kieselgel 60 F~254~, 0.25 mm) and precoated RP-18 F~254s~ plates (Merck) were used for thin-layer chromatography (TLC) analysis. Silica gel 60 (Merck, Darmstadt, Germany, 230--400 mesh) and LiChroprep RP-18 (Merck, 40--63 µm) were used for column chromatography. High-performance liquid chromatography (HPLC) (Hitachi, Tokyo, Japan) was carried out using a Hitachi L-7100 pump (Hitachi, Tokyo, Japan) equipped with a Hitachi, L-7400 UV detector (Hitachi, Tokyo, Japan) at 220 nm together with a semi-preparative reversed-phased column (Merck, Hibar LiChrospher RP-18e, 5 µm, 250 mm × 25 mm).

3.2. Animal Material {#sec3dot2-marinedrugs-16-00040}
--------------------

The soft coral *S. nanolobata* was collected by hand using scuba at San-Shin-Tai, Taitong County, Taiwan, in July 2008, at a depth of 7 m. A voucher specimen (SST-009) was deposited in the Department of Marine Biotechnology and Resources, National Sun Yat-sen University.

3.3. Extraction and Separation {#sec3dot3-marinedrugs-16-00040}
------------------------------

The frozen soft coral (3.0 kg) was chopped into small pieces (about 1 cm) and extracted with acetone in a percolator at room temperature. The acetone extract (30.0 g) of *S. nanolobata* was concentrated under reduced pressure to a brown gum, which was partitioned between EtOAc and H~2~O. The EtOAc-soluble fraction (30 g) was applied to Si 60 CC using *n*-hexane--EtOAc mixtures of increasing polarity for elution. Fraction 12, eluted with *n*-hexane--EtOAc (6:1), was further purified by reverse-phase HPLC (MeOH--H~2~O, 60:40) to obtain **1** (1.5 mg). Fraction 3, eluted with *n*-hexane--EtOAc (80:1), was further purified by reverse-phase HPLC (MeOH--H~2~O, 85:15) to afford **2** (2.6 mg). Fraction 18, eluted with *n*-hexane--EtOAc (1:4), was further purified by reverse-phase HPLC (MeOH--H~2~O, 65:35) to obtain **3** (5.0 mg).

Sinubatin A (**1**): Colorless oil; ${\lbrack\mathsf{\alpha}\rbrack}_{D}^{25}$ −19.2 (*c* 0.38, CHCl~3~); IR (neat) ν~max~ 2934, 1742, 1442, 1373 and 1420 cm^−1^; ^1^H and ^13^C NMR data, see [Table 1](#marinedrugs-16-00040-t001){ref-type="table"}; ESI-MS *m*/*z* 359 \[M + Na\]^+^; HR-ESI-MS *m*/*z* 359.1837 (calcd. for C~19~H~28~O~5~Na, 359.1834).

Sinubatin B (**2**): Colorless oil; ${\lbrack\mathsf{\alpha}\rbrack}_{D}^{25}$ +17.2 (*c* 0.65, CHCl~3~); IR (neat) ν~max~ 2961, 2925, 1261, 1094, 1020, 799 cm^−1^; ^1^H and ^13^C NMR data, see [Table 2](#marinedrugs-16-00040-t002){ref-type="table"}; ESIMS *m*/*z* 309 \[M + Na\]^+^; HR-ESI-MS *m*/*z* 309.1832 (calcd. for C~19~H~26~O~2~Na, 309.1830).

3.4. Biological Assay {#sec3dot4-marinedrugs-16-00040}
---------------------

Cytotoxicity assay and anti-HCMV assay were conducted as previously described \[[@B9-marinedrugs-16-00040]\].

4. Conclusions {#sec4-marinedrugs-16-00040}
==============

The chemical study of soft coral *S. nanolobata* led to the isolation of a novel tetranorditerpenoid, sinubatin A (**1**) (having an unprecedented carbon skeleton), a new norditerpenoid, sinubatin B (**2**) (a 4,5-epoxycaryophyllene possessing an unusual methylfuran moiety side chain), and gibberosin J (**3**). Compound **3** exhibited cytotoxicity toward P-388, A549, and HT-29 with ED~50~ values of 1.0, 1.2. and 0.5 μg/mL, respectively. However, compounds **1** and **2** were not cytotoxic to P-388, A549 and HT-29 cell lines. Compounds **1**--**3** did not show anti-HCMV activity.
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marinedrugs-16-00040-t001_Table 1

###### 

NMR spectral data of **1**.

  Position   δ~H~ *^a^*   (*J* in Hz)      δ~C~ *^b^*   Type    COSY          HMBC                                NOESY
  ---------- ------------ ---------------- ------------ ------- ------------- ----------------------------------- ------------------
  1          2.34         m                45.3,        CH      2, 9          11, 12                              5
  2α         1.45         m                27.7,        CH~2~   1             \-                                  \-
  2β         1.57         m                1, 3β        \-      9                                                 
  3α         1.00         td (12.8, 4.8)   38.4,        CH~2~   2β            1, 4, 16                            3β, 5
  3β         2.09         m                2β           \-      3α                                                
  4          \-           \-               59.6,        C                     \-                                  \-
  5          2.92         dd (10.8, 4.0)   63.8,        CH      6β, 16        \-                                  1, 3α
  6α         2.30         m                30.2,        CH~2~   \-            \-                                  \-
  6β         1.31         m                5            \-      6α                                                
  7α         2.16         m                29.2,        CH~2~   6α            6, 9                                6β
  7β         2.32         m                6α           8, 15   \-                                                
  8          \-           \-               150.7,       C                     \-                                  \-
  9          2.71         td (9.6, 9.2)    48.7,        CH      1, 10α, 10β   \-                                  2β, 10β, 14, 15a
  10α        1.85         dd (10.4, 9.6)   36.2,        CH~2~   9             9, 11, 12, 14                       \-
  10β        1.74         dd (10.4, 9.2)   9            8       9, 14                                             
  11         \-           \-               38.3,        C       \-            \-                                  \-
  12         4.74         s                79.4,        CH      \-            10, 11, 13, 14, carbonyl (OAc-12)   1, 10α
  13         \-           \-               169.2,       qC      \-            \-                                  \-
  14         1.14         s                15.2,        CH~3~   \-            1, 10, 11, 12                       2α, 2β, 9, 10β
  15a        5.01         s                114.0,       CH~2~   \-            7, 8, 9                             9, 10α, 15b
  15b        4.90         s                \-           7, 9    7α                                                
  16         1.19         s                17.1,        CH~3~   5             3, 4, 5                             3β, 6β, 9
  OAc-12     2.15         s                20.6,        CH~3~   OMe-13        carbonyl (OAc-12)                   \-
  \-         \-           170.8,           C            \-      \-            \-                                  
  OMe-13     3.71         s                51.9,        CH~3~   OAc-12        13                                  \-

*^a^* Spectrum recorded at 400 MHz in CDCl~3~. *^b^* Spectrum recorded at 100 MHz in CDCl~3~.

marinedrugs-16-00040-t002_Table 2

###### 

NMR spectral data of **2**.

  Position   δ~H~ *^a^*   (*J* in Hz)            δ~C~ *^b^*   Type         COSY          HMBC              NOESY
  ---------- ------------ ---------------------- ------------ ------------ ------------- ----------------- ----------------------
  1          2.47         td (10.0,8.4)          49.3,        CH           2β, 9         3, 8, 9, 11, 17   2α, 3α, 5
  2α         1.72         m                      27.2,        CH~2~        3α, 3β        1, 3, 11          1, 3α, 3β
  2β         1.54         m                      1, 3α, 3β    1            3β, 9                           
  3α         0.98         td (13.2, 5.2)         38.8,        CH~2~        2α, 2β, 19    2, 4, 5, 19       1, 2α, 5
  3β         2.07         dt (13.2,3.6)          2α, 2β       \-           2α, 2β, 19                      
  4          \-           \-                     59.7,        C            \-            \-                \-
  5          2.92         dd (10.4, 4.0)         63.7,        CH           6α, 6β        3, 6              1, 3α, 6α
  6α         2.28         m                      30.1,        CH~2~        5             4, 5, 7           5
  6β         1.37         m                      5, 7α, 7β    \-           7β                              
  7α         2.44         ddd (12.8, 8.0, 4.0)   29.8,        CH~2~        6β            5, 6, 8, 9        18b
  7β         2.17         ddd (12.8, 8.0, 4.4)   6α, 6β       5, 6, 8, 9   9                               
  8          \-           \-                     151.4,       C            \-            \-                \-
  9          2.74         td (9.6, 8.4)          47.9,        CH           1, 10α, 10β   1, 7, 8, 10       2β, 7β, 10β, 18a, 19
  10α        2.33         dd (10.8, 9.6)         37.8,        CH~2~        9, 10β        9, 11, 12, 17     18a
  10β        1.87         dd (10.8, 8.4)         9, 10α       1, 16        9, 10α, 17                      
  11         \-           \-                     36.9,        C            \-            \-                \-
  12         \-           \-                     160.2,       C            \-            \-                \-
  13         5.83         d (4.0)                103.7,       CH           \-            \-                17
  14         5.84         dd (4.0, 0.8)          105.8,       CH           \-            \-                16
  15         \-           \-                     150.6,       C            \-            \-                \-
  16         2.28         d (0.8)                13.6,        CH~3~        \-            14, 15            14
  17         1.35         s                      17.9,        CH~3~        \-            1, 10, 11, 12     2α, 2β, 9, 13
  18a        5.09         s                      113.5,       CH~2~        7β            7, 8, 9           9, 10α
  18b        4.93         s                      7β           7, 8, 9      7β                              
  19         1.23         s                      17.0,        CH~3~        3             3, 4, 5           3β, 9

*^a^* Spectrum recorded at 400 MHz in CDCl~3~. *^b^* Spectrum recorded at 100 MHz in CDCl~3~.
